Diabetes Medication Update

June 14, 2022
Registration


There is no cost to attend this webinar, but registration is required. 

YOU MUST LOGIN OR CREATE AN ACCOUNT BEFORE ENROLLING IN THIS EDUCATIONAL ACTIVITY. 

Once you're logged in, please select the green "ENTER" button found in the course summary box. After you register, you'll receive an email with instructions on how to complete your registration through Zoom.

If you have questions, please email Laurene Hendricks at laurene.hendricks@idph.iowa.gov.
 

Purpose

The purpose of this online activity is to provide education and professional development to diabetes educators/DSMES program staff to enhance understanding of the ADA’s current treatment algorithm, medications and their use, technology in drug therapy selection, and drug therapy plans for people with diabetes. 

Attendees will improve their knowledge and competence related to the medication(s) their diabetes patients have been prescribed, enabling them to help patients understand the purpose of the medication, the anticipated benefit/side effects, how to read labels, and the importance of taking medications as prescribed. 

Target Audience

DSMES program staff, diabetes educators, dietitians, pharmacists, and other interested healthcare providers.

Learning Objectives

  • Review the American Diabetes Association’s Standards of Medical Care in Diabetes 2022 treatment algorithm.
  • Differentiate between GLP1-RA and SGLT2i for cardiometabolic disease in people with type 2 diabetes.
  • Discuss the use of technology in drug therapy selection for people with diabetes.
  • Address drug therapy for comorbid conditions that exist in a person with diabetes.
  • Create a drug therapy plan with a rationale for a person with diabetes.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credits
  • 1.50 AOA Category 2­A
  • 1.50 CE Contact Hour(s)
  • 1.50 IBON
Course opens: 
05/13/2022
Course expires: 
06/14/2022
Event starts: 
06/14/2022 - 12:00pm CDT
Event ends: 
06/14/2022 - 1:30pm CDT
Cost:
$0.00
Rating: 
0

Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, FAPhA
Associate Professor of Pharmacy Practice, Drake University

  • Education: Doctor of Pharmacy Practice (PharmD), Drake University, 1999.
  • Registered Pharmacist Licensure: 
    • Illinois, 1999-present
    • Iowa, 2012- present
  • Certification: 
    • Board Certified Ambulatory Care Pharmacist (BCACP), Board of Pharmacy Specialties. Issued December 2015, Expires December  2022.
    • Certified Diabetes Care and Education Specialist, June 2010. Credentialed by examination via National Certification Board for Diabetes Care and Education (NCBDCE). Renewed December 2015, 2020.

ACCREDITATION STATEMENTS

  • MD:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and Iowa Department of Public Health. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.5 continuing education contact hour(s). No partial credit will be awarded.
  • Other healthcare providers: This live activity is designated for 1.5 AMA PRA Category 1 Credit(s)™.

EDUCATIONAL GRANTS

No ineligible company provided financial support for this continuing education activity.

DISCLOSURES

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

  • Laurene Hendricks - Activity Director and Moderator
  • Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, FAPhA - Planning Committee Member and Speaker

The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. 

Disclaimer

This webinar is supported by Cooperative Agreement NU58DP006514 from the Centers for Disease Control and Prevention (CDC).  Contents are the responsibility of the authors and do not necessarily represent the official views of the CDC, the United States Department of Health and Human Services, or the Iowa Department of Public Health.

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 1.50 AMA PRA Category 1 Credits
  • 1.50 AOA Category 2­A
  • 1.50 CE Contact Hour(s)
  • 1.50 IBON

Price

Cost:
$0.00
Please login or Create an Account to take this course.

 

There is no cost to attend this webinar but registration is required. 

Please select the green "ENTER" button. You will receive an email with instructions on how to complete your registration through Zoom.